Sign in

CIK 0001731348 · Large accelerated filer

Tilray Brands, Inc.

Sign in to watch
Ticker
TLRY
Exchange
Nasdaq
Industry
Medicinal Chemicals & Botanical Products
FY end
May 31
Entity type
operating
EIN
824310622
Phone
519.322.8800
Business address
445 PARK AVENUE, NEW YORK, NY, 10022
Former names
Tilray, Inc.
  1. 4 Shares withheld for taxes President and CEO gave up 642,450 shares (to pay taxes)
  2. 4 Shares withheld for taxes Chief Financial Officer gave up 92,649 shares (to pay taxes)
  3. 4 Shares withheld for taxes Global General Counsel gave up 84,962 shares (to pay taxes)
  4. 4 Shares withheld for taxes Chief Strategy Officer gave up 94,459 shares (to pay taxes)
  5. 4 Open-market buy Global General Counsel bought 2,500 shares at $4.43 ($11,075)
  6. 4 Open-market buy Chief Financial Officer bought 10,000 shares at $4.62 ($46,200)
  7. 4 Open-market buy Chief Strategy Officer bought 2,500 shares at $4.78 ($11,950)
  8. 4 Shares withheld for taxes President and CEO gave up 289,431 shares (to pay taxes)
  9. 4 Shares withheld for taxes Chief Financial Officer gave up 39,370 shares (to pay taxes)
  10. 4 Shares withheld for taxes Global General Counsel gave up 59,265 shares (to pay taxes)
  11. 4 Shares withheld for taxes Chief Strategy Officer gave up 63,498 shares (to pay taxes)
  12. 4 Shares withheld for taxes Director gave up 21,552 shares (to pay taxes)
  13. 4 Option exercise Director acquired 43,104 shares (option exercise)
  14. 4 Shares withheld for taxes Director gave up 21,552 shares (to pay taxes)
  15. 4 Option exercise Director acquired 43,104 shares (option exercise)
  16. 4 Shares withheld for taxes Director gave up 21,552 shares (to pay taxes)
  17. 4 Option exercise Director acquired 43,104 shares (option exercise)
  18. 4 Open-market sale Director sold 33,556 shares at $6.94 ($232,879)
  19. 4 Option exercise Director acquired 12,438 shares (option exercise)
  20. 4 Option exercise President and CEO acquired 706,216 shares (option exercise)

Page 1 of 17 · 334 filings